CMED.TO - CanniMed Therapeutics Inc.

Toronto - Toronto Delayed Price. Currency in CAD
27.00
-1.50 (-5.26%)
At close: 3:59PM EDT
Stock chart is not supported by your current browser
Previous Close28.50
Open28.50
Bid27.01 x 0
Ask27.09 x 0
Day's Range27.00 - 28.50
52 Week Range7.32 - 46.00
Volume52,208
Avg. Volume174,194
Market Cap681.993M
BetaN/A
PE Ratio (TTM)188.81
EPS (TTM)0.14
Earnings DateJun 11, 2018 - Jun 15, 2018
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est24.00
  • CNW Group19 days ago

    Aurora Completes CanniMed Acquisition

    CanniMed Shares Delisted from TSX TSX: ACB  TSX: CMED EDMONTON , May 1, 2018 /CNW/ - Aurora Cannabis Inc. (" Aurora " or the " Company ") (TSX:ACB) (OTCQB:ACBFF) (Frankfurt : 21P; WKN:A1C4WM) ...

  • ACCESSWIRE20 days ago

    Today’s Research Reports on VentriPoint Diagnostics, Cotinga Pharmaceuticals, Knight Therapeutics and CanniMed Therapeutics

    NEW YORK, NY / ACCESSWIRE / April 30, 2018 / Research Driven Investing strives to provide investors with free daily equity research reports analyzing major market events. Take a few minutes to register ...

  • CNW Grouplast month

    Aurora Cannabis Gains Exclusive License to Novel Patented Sub-Lingual Wafer Technology from CTT Pharmaceutical

    WKN: A1C4WM), CanniMed Therapeutics Inc. ("CanniMed") (TSX:CMED.TO - News) and CTT Pharmaceutical Holdings, Inc., ("CTT") (OTC:CTTH - News) announced today that further to the CanniMed/CTT news release of February 17, 2017, the companies have entered into a three-way agreement that provides Aurora, through its ownership of CanniMed, with joint exclusivity on the distribution in Canada of CTT's novel, patented drug delivery technologies. This collaboration includes the licensing by CTT to CanniMed and Aurora of six patents related to cannabinoid delivery for pain management that will enable CanniMed and Aurora to exclusively develop and commercialize this unique, sub-lingual (beneath the tongue) wafer, drug delivery system in Canada.

  • 3 Stocks That Are Crushing the TSX This Year
    The Motley Foollast month

    3 Stocks That Are Crushing the TSX This Year

    Should you buy market-beating stocks like Bombardier, Inc. (TSX:BBD.B) and Canfor Corporation (TSX:CFP) now?

  • Baystreetlast month

    Stocks in play: CanniMed Therapeutics Inc.

    Announced that Aurora Cannabis has exercised its right under the compulsory acquisition provisions in ...

  • CNW Grouplast month

    Aurora Cannabis Commences Compulsory Acquisition of Remaining CanniMed Shares

    TSX: ACB  TSX: CMED EDMONTON , April 13, 2018 /CNW/ - Aurora Cannabis Inc. (" Aurora ") (TSX: ACB) (OTCQB: ACBFF) (Frankfurt : 21P; WKN: A1C4WM) announced today that the Company has exercised ...

  • Are Pot Stocks Drying Up?
    The Motley Foollast month

    Are Pot Stocks Drying Up?

    Canopy Growth Corp. (TSX:WEED), Aurora Cannabis Inc. (TSX:ACB) and Aphria Inc. (TSX:APH) have all struggled as of late, but there is no need to panic.

  • Baystreet2 months ago

    Stocks in play: CanniMed Therapeutics Inc.

    And Aurora Cannabis Inc. announced today that CanniMed has entered into a Letter of Intent to become ...

  • CNW Group2 months ago

    CanniMed Signs Letter of Intent with Pharmasave

    WKN: A1C4WM) and CanniMed Therapeutics Inc. ("CanniMed") (TSX:CMED.TO - News) announced today that CanniMed has entered into a Letter of Intent to become a preferred supplier of medical cannabis to Pharmasave. A member governed cooperative of more than 650 independently owned community pharmacies across the country, Pharmasave is one of Canada's leading independent community pharmacies.

  • The Canadian Press2 months ago

    Most actively traded companies on the TSX

    Some of the most active companies traded Monday on the Toronto Stock Exchange:

  • CanniMed CEO resigns, Aurora Cannabis exec tapped interim CEO
    Reuters2 months ago

    CanniMed CEO resigns, Aurora Cannabis exec tapped interim CEO

    Aurora Cannabis senior vice president Andrċ Jérôme, previously tasked with heading the acquisition of CanniMed, will serve as interim CEO. Aurora is almost set to close the purchase of CanniMed, creating the world's most valuable weed firm after months of tensions between the companies.

  • CNW Group2 months ago

    Andrċ Jérôme Appointed Interim CEO of CanniMed

    WKN: A1C4WM) and CanniMed Therapeutics Inc. ("CanniMed") (TSX:CMED.TO - News) announced today that Mr. Brent Zettl has resigned from his position as CEO of CanniMed, effective immediately, to pursue other opportunities. Mr. Zettl has agreed to remain available to CanniMed and Aurora in an advisory capacity to assist during the integration period. "CanniMed is the pioneer in the Canadian medical cannabis industry and this is in no small part thanks to Brent and the huge contributions he has made to the development of the sector.

  • Baystreet2 months ago

    Stocks in play: CanniMed Therapeutics Inc.

    Announced today that with the second take-up under Aurora Cannabis Inc.’s offer to acquire all of the ...

  • CNW Group2 months ago

    Aurora Cannabis Finalizes Largest Acquisition in Cannabis Industry History

    WKN: A1C4WM) announced today that with the second take-up under its offer to acquire all of the outstanding shares of CanniMed Therapeutics Inc. ("CanniMed") (TSX:CMED.TO - News), the Company now owns approximately 95.9% of CanniMed common shares (the "CanniMed Shares"). The Company intends to acquire the remaining outstanding shares it does not already own through a compulsory share acquisition, pursuant to the Canada Business Corporations Act. The transaction unites Aurora, one of the world's largest and fastest growing cannabis companies, with CanniMed, a pioneering cannabis company that has been operating in the industry longer than any other competitor, and whose brand strongly resonates with the medical community.

  • ACCESSWIRE2 months ago

    Today’s Research Reports on Knight Therapeutics, Crescita Therapeutics, CanniMed Therapeutics and Cipher Pharmaceuticals

    NEW YORK, NY / ACCESSWIRE / March 22, 2018 / Research Driven Investing strives to provide investors with free daily equity research reports analyzing major market events. Take a few minutes to register ...

  • Do You Know Which Cannabis Stocks Are Outperforming the Market?
    The Motley Fool2 months ago

    Do You Know Which Cannabis Stocks Are Outperforming the Market?

    HORIZNS MARIJUNA LF CL A UNT ETF (TSX:HMMJ) is up an impressive 95% since the start of November. But several cannabis stocks have fared even better. Find out which ones.

  • Will Aurora Cannabis Inc.’s Recent Moves Make it a Market Beater With Huge Upside in 2019?
    The Motley Fool2 months ago

    Will Aurora Cannabis Inc.’s Recent Moves Make it a Market Beater With Huge Upside in 2019?

    Aurora Cannabis Inc. (TSX:ACB) is setting the stage for massive post-legalization growth, but is the potential reward worth the risk?

  • Business Wire2 months ago

    CanniMed Therapeutics Inc. Announces First Quarter Results

    CanniMed Therapeutics Inc. today released its unaudited financial results of operations for the three months ended January 31, 2018. The information in this news release should be read in conjunction with the Company’s condensed consolidated interim financial statements and notes thereto for the three months ended January 31, 2018 and the Company’s audited consolidated financial statements and notes ...

  • Aurora Cannabis Inc. Has Been Busy: 3 Big Moves Last Month
    The Motley Fool2 months ago

    Aurora Cannabis Inc. Has Been Busy: 3 Big Moves Last Month

    Aurora Cannabis Inc. (TSX:ACB) made several big moves lasts month to secure distribution and bolster its product line. Will it help the company come July 1, when recreational cannabis becomes legal?

  • Why Canopy Growth Corp. Is the Best Pot Stock to Buy Today
    The Motley Fool2 months ago

    Why Canopy Growth Corp. Is the Best Pot Stock to Buy Today

    There are several reasons why Canopy Growth Corp. (TSX:WEED) is a cut above its competition.

  • Business Wire2 months ago

    CanniMed Therapeutics Inc. Announces Quarterly Results Release Date

    CanniMed Therapeutics Inc. announces that it plans to release its financial results for the three months ended January 31, 2018 before markets open on Monday, March 19, 2018.

  • Business Wire2 months ago

    Changes to CanniMed Therapeutics Board Following Share Take-Up by Aurora Cannabis

    Aurora Cannabis Inc. and CanniMed Therapeutics Inc. announced today that following the successful take up and payment of approximately 86.8% of the issued and outstanding of CanniMed Shares, three Aurora Cannabis appointees will join the CanniMed Board of Directors, effective immediately.

  • CNW Group2 months ago

    Changes to CanniMed Therapeutics Board Following Share Take-Up by Aurora Cannabis

    TSX: ACB  TSX: CMED EDMONTON and SASKATOON , March 15, 2018 /CNW/ - Aurora Cannabis Inc. (" Aurora ") (TSX: ACB) (OTCQB: ACBFF) (Frankfurt : 21P; WKN: A1C4WM) and CanniMed Therapeutics Inc. (" ...

  • Should Aurora Cannabis Inc. Investors Worry as More CanniMed Therapeutics Inc. Investors Opt for Cash?
    The Motley Fool2 months ago

    Should Aurora Cannabis Inc. Investors Worry as More CanniMed Therapeutics Inc. Investors Opt for Cash?

    Could the high uptake of cash offer to CanniMed Therapeutics Inc. (TSX:CMED) investors imply a depressed near-term view on Aurora Cannabis Inc.'s (TSX:ACB) valuation?

  • Aurora Cannabis Inc. Investors: More Dilution Is Ahead
    The Motley Fool2 months ago

    Aurora Cannabis Inc. Investors: More Dilution Is Ahead

    On Friday, Aurora Cannabis Inc. (TSX:ACB) announced it has agreed to terms with CanniMed Therapeutics Inc. (TSX:CMED) and will begin integrating the firm. Here's what it means for shareholders in terms of dilution.